99 related articles for article (PubMed ID: 18284062)
1. [DNA methylation and prostate cancer].
Zhou SG; Sun YH; Gao JP
Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1108-12. PubMed ID: 18284062
[TBL] [Abstract][Full Text] [Related]
2. The emerging roles of DNA methylation in the clinical management of prostate cancer.
Perry AS; Foley R; Woodson K; Lawler M
Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
[TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation and prostate cancer].
Colombel M; Ricci E; Picard A; Bourrelly E;
Prog Urol; 2010 Jun; 20(6):408-15. PubMed ID: 20538204
[TBL] [Abstract][Full Text] [Related]
4. The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.
Murphy TM; Perry AS; Lawler M
Endocr Relat Cancer; 2008 Mar; 15(1):11-25. PubMed ID: 18310272
[TBL] [Abstract][Full Text] [Related]
5. [Role of RASSF1A hypermethylation in prostate cancer].
Wang YC; Yu ZH; Chen LB
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):822-5. PubMed ID: 17929562
[TBL] [Abstract][Full Text] [Related]
6. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
[TBL] [Abstract][Full Text] [Related]
7. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients.
Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951
[TBL] [Abstract][Full Text] [Related]
8. [Association of mating type switching/sucrose non-fermenting complex with prostate cancer].
Yang J; Liu JH; Li BY
Zhonghua Nan Ke Xue; 2008 Oct; 14(10):935-8. PubMed ID: 19157109
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer.
Hopkins TG; Burns PA; Routledge MN
Urology; 2007 Jan; 69(1):11-6. PubMed ID: 17270599
[No Abstract] [Full Text] [Related]
11. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
[TBL] [Abstract][Full Text] [Related]
12. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
[TBL] [Abstract][Full Text] [Related]
13. Methylated genes as new cancer biomarkers.
Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology of prostate cancer.
Karayi MK; Markham AF
Prostate Cancer Prostatic Dis; 2004; 7(1):6-20. PubMed ID: 14999233
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor beta2 hypermethylation: implications for prostate cancer detection, prevention, and therapy.
Lotan R; Lotan Y
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3935-6. PubMed ID: 15217922
[No Abstract] [Full Text] [Related]
17. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
18. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness.
Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F
J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327
[TBL] [Abstract][Full Text] [Related]
19. Potential screening test for prostate cancer.
Expert Rev Mol Diagn; 2001 Nov; 1(4):367-8. PubMed ID: 11901845
[No Abstract] [Full Text] [Related]
20. Genetic changes and DNA damage responses in the prostate.
Hällström TM; Laiho M
Prostate; 2008 Jun; 68(8):902-18. PubMed ID: 18324675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
